Literature DB >> 31698238

Granger causality analysis in combination with directed network measures for classification of MS patients and healthy controls using task-related fMRI.

Farzad Azarmi1, Seyedeh Naghmeh Miri Ashtiani2, Ahmad Shalbaf1, Hamid Behnam2, Mohammad Reza Daliri3.   

Abstract

Several studies have already assessed brain network variations in multiple sclerosis (MS) patients and healthy controls (HCs). The underlying neural system's functioning is apparently too complicated, however. Therefore, the neural time series' analysis through new methods is the aim of any recent research. Functional magnetic resonance imaging (fMRI) is a prominent modality for investigating the human brain's neural substrate, especially when cognitive impairment occurs. The present study was an attempt to investigate the brain network's differences between MS patients and HCs using graph-theoretic measures constructed by an effective connectivity measure through statistical tests. The results of the significant measures were then evaluated through machine learning methods. To this end, we gathered blood-oxygen level dependent (BOLD) fMRI data of the participants during the execution of paced auditory serial addition test (PASAT). Granger causality analysis (GCA) was then employed between brain regions' time series on each subject in order to construct a brain network. Afterward, the Wilcoxon rank-sum test was implemented to find the alteration of brain networks between the mentioned groups. According to the results, Global flow coefficient was significantly different between HCs and patients. Moreover, MS disease impacted several areas of the brain including Hippocampus, Para Hippocampal, Thalamus, Cuneus, Superior temporal gyrus, Heschl, Caudate, Medial Frontal Superior Gyrus, Fusiform, Pallidum, and several parts of Cerebellum in centrality measures and local flow coefficient. Most of the obtained regions were related to the cognitive impacts of the disease. We also found the best subset of graph features by means of Fisher score, and classified them to evaluate the features strength for the discrimination of MS patients from HCs via several machine learning methods. Having used the combination of Wilcoxon rank-sum test and Fisher score, we were able to classify MS patients from HCs using linear support vector machine (SVM) with an accuracy of 95%. With regard to the few existing studies on brain network of MS patients, especially during a cognitive task execution, our findings showed that the selected graph measures by Wilcoxon rank-sum test and Fisher score from the GCA-based brain networks resulted in a promising classification accuracy.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Brain network; Effective connectivity; Machine learning; PASAT; Support vector machine; fMRI

Year:  2019        PMID: 31698238     DOI: 10.1016/j.compbiomed.2019.103495

Source DB:  PubMed          Journal:  Comput Biol Med        ISSN: 0010-4825            Impact factor:   4.589


  4 in total

1.  NLGC: Network localized Granger causality with application to MEG directional functional connectivity analysis.

Authors:  Behrad Soleimani; Proloy Das; I M Dushyanthi Karunathilake; Stefanie E Kuchinsky; Jonathan Z Simon; Behtash Babadi
Journal:  Neuroimage       Date:  2022-07-21       Impact factor: 7.400

Review 2.  Machine Learning Approaches in Study of Multiple Sclerosis Disease Through Magnetic Resonance Images.

Authors:  Faezeh Moazami; Alain Lefevre-Utile; Costas Papaloukas; Vassili Soumelis
Journal:  Front Immunol       Date:  2021-08-11       Impact factor: 7.561

3.  WISDoM: Characterizing Neurological Time Series With the Wishart Distribution.

Authors:  Carlo Mengucci; Daniel Remondini; Gastone Castellani; Enrico Giampieri
Journal:  Front Neuroinform       Date:  2021-01-26       Impact factor: 4.081

4.  Altered Functional Connectivity in White and Gray Matter in Patients With Multiple Sclerosis.

Authors:  Jing Huang; Muwei Li; Qiongge Li; Zhipeng Yang; Bowen Xin; Zhigang Qi; Zheng Liu; Huiqing Dong; Kuncheng Li; Zhaohua Ding; Jie Lu
Journal:  Front Hum Neurosci       Date:  2020-12-02       Impact factor: 3.169

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.